Author

Cǎlin Muntean

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Carbapenem-Resistant and Extensively Drug-Resistant Gram-Negative Healthcare-Associated Infections in a Romanian Tertiary Infectious Diseases Hospital: Phenotypic Landscape, Stewardship Gaps and Outcomes (2024–2025)

Background/Objectives: Romania reports among the highest rates of carbapenem-resistant Gram-negative bacteria in the European Union, but patient-level data on healthcare-associated infections (HAIs) are scarce. We characterised carbapenem resistance, in-hospital outcomes, and carbapenem prescribing in a 24-month HAI co...

Răzvan Roșca, Cǎlin Muntean, M. Frandeș et al. · Antibiotics · 0 citations

Review Open access Sep 2026

The Gut–Skin Axis in Pediatric Atopic Dermatitis: Nutritional Modulation, Microbiome Interactions, and Emerging Precision Approaches

Background/Objectives: Pediatric atopic dermatitis (AD) is a barrier-driven inflammatory skin disease with systemic immune and microbial correlates. The gut–skin axis offers a biologically plausible framework through which early-life nutrition, gut microbial metabolism, intestinal barrier function, and immune maturatio...

Raluca Miulescu, Mihnea Costescu, R. Marin et al. · Nutrients · 0 citations

Review Open access Aug 2026

Imaging and Hemodynamic Mechanisms of Cardiac Remodeling with SGLT2 Inhibitors Across Heart Failure Phenotypes: A Systematic Review

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, originally developed as glucose-lowering agents for type 2 diabetes mellitus, have been shown in large, randomized trials to improve clinical outcomes in heart failure (HF) across the ejection fraction (EF) spectrum. The imaging-derived and hemodynamic chan...

D. Buzzi, Teodora Mateoc-Sîrb, Samuel Ardelean et al. · Biomedicines · 0 citations